Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 8/2007

01-08-2007 | Letter

Comment on: Krabbe KS, Nielsen AR, Krogh-Madsen R et al (2007) Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50:431–438

Authors: G. N. Chaldakov, A. B. Tonchev, L. Manni, M. G. Hristova, V. Nikolova, M. Fiore, D. Vyagova, V. N. Peneva, L. Aloe

Published in: Diabetologia | Issue 8/2007

Login to get access

Excerpt

To the Editor:
Some men see things as they are and say: ‘Why?’ I dream things that never were and say: ‘Why not!’
…
Literature
1.
Krabbe KS, Nielsen AR, Krogh-Madsen R et al (2007) Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50:431–438PubMedCrossRef
2.
Manni L, Nikolova V, Vyagova D, Chalakov GN, Aloe L (2005) Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol 102:169–171PubMedCrossRef
3.
Chaldakov GN, Fiore M, Stankulov IS et al. (2004) Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog Brain Res 146:279–289PubMedCrossRef
4.
Chaldakov GN, Fiore M, Tonchev AB, Aloe L (2006) Adipopharmacology, a novel drug discovery approach: a metabotrophic perspective. Lett Drug Des Discov 3:503–505
5.
Geroldi D, Minoretti P, Emanuele E (2006) Brain-derived neurotrophic factor and the metabolic syndrome: more than just hypothesis. Med Hypotheses 67:195–196PubMedCrossRef
6.
Chen Y, Yang R, Yao L, Sun Z, Wang R, Dai Y (2007) Differential expression of neurotrophins in penises of streptozotocin-induced diabetic rats. J Androl 28:306–312PubMedCrossRef
7.
Cai D, Holm JM, Duignan IJ et al (2006) BDNF-mediated enhancement of inflammation and injury in the aging heart. Physiol Genomics 24:191–197PubMed
8.
Ejiri J, Inoue N, Kobayashi S et al (2005) Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease. Circulation 112:2114–2120PubMedCrossRef
9.
Suwa M, Kishimoto H, Nofuji Y et al (2006) Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism 55:852–857PubMedCrossRef
10.
Lommatzsch M, Virchow JC (2006) Letter regarding article by Ejiri et al, ‘Possible role of brain-derived neurotrophic factor in the pathogenesis of coronary artery disease.’ Circulation 113:e724PubMedCrossRef
Metadata
Title
Comment on: Krabbe KS, Nielsen AR, Krogh-Madsen R et al (2007) Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 50:431–438
Authors
G. N. Chaldakov
A. B. Tonchev
L. Manni
M. G. Hristova
V. Nikolova
M. Fiore
D. Vyagova
V. N. Peneva
L. Aloe
Publication date
01-08-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 8/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0706-0

Other articles of this Issue 8/2007

Diabetologia 8/2007 Go to the issue

Article

Stimulation of glycogen synthesis and inactivation of phosphorylase in hepatocytes by serotonergic mechanisms, and counter-regulation by atypical antipsychotic drugs

Review

Insulin resistance and the metabolic syndrome—or the pitfalls of epidemiology

Article

The c-Jun N-terminal kinase JNK participates in cytokine- and isolation stress-induced rat pancreatic islet apoptosis

Article

Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus

Letter

The accelerator hypothesis cannot be tested using the type 2 diabetes gene, TCF7L2

Article

Dominant negative mutant forms of the cAMP response element binding protein induce apoptosis and decrease the anti-apoptotic action of growth factors in human islets
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits